These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 30205304)

  • 1. Development of a novel HPLC method for the determination of the impurities in desonide cream and characterization of its impurities by 2D LC-IT-TOF MS.
    Wang J; Zheng S; Xu Y; Hu H; Shen M; Tang L
    J Pharm Biomed Anal; 2018 Nov; 161():399-406. PubMed ID: 30205304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a trap-free two-dimensional liquid chromatography combined with ion trap/time-of-flight mass spectrometry for separation and characterization of impurities and isomers in cefpiramide.
    Wang J; Xu Y; Wen C; Wang Z
    Anal Chim Acta; 2017 Nov; 992():42-54. PubMed ID: 29054149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation and characterization of unknown impurities in cefonicid sodium by trap-free two-dimensional liquid chromatography combined with ion trap time-of-flight mass spectrometry.
    Wang J; Xu Y; Zhang Y; Wang H; Zhong W
    Rapid Commun Mass Spectrom; 2017 Sep; 31(18):1541-1550. PubMed ID: 28688234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation and characterization of unknown impurities in rutin tablets using trap-free two-dimensional liquid chromatography coupled with ion trap/time-of-flight mass spectrometry.
    Wang J; Ren X; Wen C; Xu Y; Chen Y
    Rapid Commun Mass Spectrom; 2020 May; 34(10):e8739. PubMed ID: 31986235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation and characterization of allergenic polymerized impurities from cephalosporin for injection by trap free two-dimensional high performance size exclusion chromatography × reversed phase liquid chromatography coupled with ion trap time-of-flight mass spectrometry.
    Xu Y; Wang D; Zhu B; Tang L; Wang J
    J Pharm Biomed Anal; 2018 May; 154():425-432. PubMed ID: 29579634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation and characterization of allergic polymerized impurities in cephalosporins by 2D-HPSEC×LC-IT-TOF MS.
    Xu Y; Wang D; Tang L; Wang J
    J Pharm Biomed Anal; 2017 Oct; 145():742-750. PubMed ID: 28806571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of four unknown impurities in azithromycin and erythromycin imino ether using two-dimensional liquid chromatography coupled to high-resolution quadrupole time-of-flight mass spectrometry and nuclear magnetic resonance.
    Jin Y; Xu Y; Zhou J; Zhou Z; Wang J
    Rapid Commun Mass Spectrom; 2020 Jun; 34(11):e8772. PubMed ID: 32112476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impurity profile analysis of amphotericin B using on-line two-dimensional high performance liquid chromatography-quadrupole time-of-flight mass spectrometry].
    Weng RW; Wang XT; Wen HL; Liu H
    Se Pu; 2024 Apr; 42(5):432-444. PubMed ID: 38736386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation and Characterization of Unknown Impurities and Isomers in Cefminox Sodium and Study of the Forming Mechanisms of Impurities by Liquid Chromatography Coupled with Ion Trap/Time-Of-Flight Mass Spectrometry.
    Xu Y; Wang D; Tang L; Wang J
    J Chromatogr Sci; 2019 Mar; 57(3):204-212. PubMed ID: 30395207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of teicoplanin impurities by two-dimensional ultra performance liquid chromatography-quadrupole/time-of-flight mass spectrometry].
    Shao W; Chen Y; Yuan H; Jin M; Zhou X; Qin Y; Yang H; He Y
    Se Pu; 2023 Feb; 41(2):195-204. PubMed ID: 36725716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of polymerized impurities in cefoxitin sodium for injection by two-dimensional chromatography coupled with time-of-flight mass spectrometry.
    Ji F; Zhang W; Wang M; Yuan W; Wang M; Li X; Adams E
    Talanta; 2024 Mar; 269():125378. PubMed ID: 38006732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the polymerized impurities in cefmetazole sodium based on novel separation principle by liquid chromatography tandem ion trap/time-of-flight mass spectrometry.
    Wang F; Ren X; Zhu B; Zhang F; Gao J; Hong L; Wang J
    J Pharm Biomed Anal; 2022 Jun; 215():114790. PubMed ID: 35483231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the impurity profile and polymerized impurity in mezlocillin sodium by multiple heart-cutting two-dimensional liquid chromatography coupled with ion trap time-of-flight mass spectrometry.
    Wang J; Zhou J; Xu Y; Zhu B; Li H
    Rapid Commun Mass Spectrom; 2019 Sep; 33(17):1410-1419. PubMed ID: 31148276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of impurity profiling of arbekacin sulfate by ion-pair liquid chromatography coupled with pulsed electrochemical detection and online ion suppressor-ion trap-time off light mass spectrometry.
    Chen Z; Zhu X; Geng Y; Dai J; Tang S; Adams E; Chen D; Yuan Y
    J Pharm Biomed Anal; 2022 Nov; 221():115061. PubMed ID: 36183632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of eight unknown impurities and analysis of their source in xinfujunsu and injection by liquid chromatography coupled with ion trap/time-of-flight mass spectrometry.
    Wang J; Tang K; Zhu B; Zheng S; Zheng J; Hong L
    J Pharm Biomed Anal; 2021 Sep; 204():114279. PubMed ID: 34340019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation and characterization of unknown impurities and isomers in flomoxef sodium by LC-IT-TOF MS and study of their negative-ion fragmentation regularities.
    Yu X; Wang F; Li J; Shan W; Zhu B; Wang J
    J Pharm Biomed Anal; 2017 Jun; 140():81-90. PubMed ID: 28343077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a new component and impurities in josamycin by trap-free two-dimensional liquid chromatography coupled to ion trap time-of-flight mass spectrometry.
    Liu G; Xu Y; Sang J; Zhu B; Wang J
    Rapid Commun Mass Spectrom; 2019 Jun; 33(12):1058-1066. PubMed ID: 30907019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.